• 1
    Rosenheck R, Cramer J, Xu W, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med. 1997;337:80915.
  • 2
    The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 1991;325:293302.
  • 3
    The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:13839.
  • 4
    Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:11521.
  • 5
    Stuart B, Shea D, Briesacher B. Dynamics in drug coverage of Medicare beneficiaries: finders, losers, switchers. Health Aff (Millwood). 2001;20:8699.
  • 6
    Adams AS, Soumerai SB, Ross-Degnan D. The case for a Medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health. 2001;22:4961.
  • 7
    Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin TJ, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:10727.
  • 8
    Lagnado L. The uncovered; drug costs can leave elderly a grim choice: pills or other needs; when a trip to the pharmacy costs $400, and Medicare doesn't pay for any of it; buying medicines on credit. Wall Street Journal. November 17, 1998:A1(E).
  • 9
    Heffler S, Levit K, Smith S, et al. Health spending growth up in 1999: faster growth expected in the future. Health Aff (Millwood). 2001;20:194.
  • 10
    Poisal JA, Murray LA, Chulis GS, Cooper BS. Prescription drug coverage and spending for Medicare beneficiaries. Health Care Financ Rev. 1999;20:1527.
  • 11
    U.S. Administration on Aging. Profile of older Americans, 2000. Available at: Accessed November 2, 2001.
  • 12
    Consumer Expenditure Survey. Consumer units with reference person age 65 and over by income before taxes: average annual expenditures and characteristics, 1997–98. Bureau of Labor Statistics. URL: First accessed September 20, 2001.
  • 13
    Lewin Group. Current Knowledge of Third Party Outpatient Drug Coverage for Medicare Beneficiaries. Fairfax, Va: Lewin Group; November 9, 1998.
  • 14
    Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescriptions coverage: a national survey. J Gen Intern Med. 2001;16:7939.
  • 15
    Blustein J. Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Aff (Millwood). 2000;19:21930.
  • 16
    Adams AS, Soumerai SB, Ross-Degnan D. Utilization of antihypertensive drugs among Medicare enrollees. Health Aff (Millwood). 2001;20:27686.
  • 17
    Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid: effect on therapy, cost, and equity. N Engl J Med. 1987;317:5506.
  • 18
    Fortess EE, Soumerai SB, McLaughlin TJ, Ross-Degnan D. Utilization of essential medications by vulnerable elderly after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc. 2001;49:7937.DOI: 10.1046/j.1532-5415.2001.49158.x
  • 19
    Soumerai SB, McLaughlin TH, Ross-Degnan D, Casteris CS, Bollini P. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:6505.
  • 20
    Soumerai SB & Ross-Degnan D. Inadequate drug coverage in Medicare: a call to action. N Engl J Med. 1999;340:7228.
  • 21
    Amendment 3598 to H.R. 4577. The Medicare Outpatient Drug Act of 2000. Congressional Budget Office Cost Estimate (As printed in the Congressional Record of June 22, 2000). URL: First accessed September 20, 2001.
  • 22
    Health Policy Alternatives, Inc. Prescription Drug Coverage for Medicare Beneficiaries: A side-by-side comparison of selected proposals (proposed as of July 15, 2001). Menlo Park, Calif: The Henry J. Kaiser Family Foundation; 2001. Available on URL:
  • 23
    Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:4219.
  • 24
    Soumerai SB. Statement before the U.S. House of Representatives Committee on Ways and Means, Subcommittee on Health. Economic and Clinical Effects of Access to Drug Coverage for Low-income and Chronically-ill Elderly and Disabled. Washington D.C., February,15, 2000.